| 2020 |
Hygum K, Harsløf T, Jørgensen NR, Rungby J, Pedersen SB, Langdahl BL. Bone resorption is unchanged by liraglutide in type 2 diabetes patients: a randomised controlled trial. Bone. March 2020;132:115197. |
1 |
1 |
| 2021 |
Starup-Linde J, Langdahl B, Harsløf T. Does FRAX estimate fracture risk in patients with type 1 diabetes? Bone. February 2021;143:115753. |
0 |
0 |
| 2022 |
Andersen JD, Folkestad L, Hald JD, Harsløf T, Langdahl BL, Abrahamsen B. Osteoarthritis in osteogenesis imperfecta: a nationwide register-based cohort study. Bone. January 2022;154:116222. |
1 |
1 |
| 2020 |
Sølling AS, Harsløf T, Langdahl B. Treatment with zoledronate subsequent to denosumab in osteoporosis: a randomized trial. J Bone Miner Res. October 2020;35(10):1858-1870. |
8 |
7 |
| 2021 |
Sølling AS, Harsløf T, Langdahl B. Treatment with zoledronate subsequent to denosumab in osteoporosis: a 2-year randomized study. J Bone Miner Res. July 2021;36(7):1245-1254. |
5 |
5 |
| 2021 |
Rønn SH, Harsløf T, Oei L, Pedersen SB, Langdahl BL. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial. Osteoporos Int. January 2021;32(1):185-191. |
0 |
0 |